{{ fieldsMsg }} Thank you for subscribing! If you do not receive a confirmation email in the next 15 minutes, please try again or contactinfo@fulgentgenetics.com. Sign Up {{ connect.title }} {{ connect.body }} {{ connect.link }}...
{{ fieldsMsg }} Thank you for subscribing! If you do not receive a confirmation email in the next 15 minutes, please try again or contactinfo@fulgentgenetics.com. Sign Up {{ connect.title }} {{ connect.body }} {{ connect.link }}...
Fulgent Genetics, Inc. today announced it has launched a test for monkeypox that leverages the U.S. Centers for Disease Control and Prevention’s (CDC) orthopoxvirus test.
Fulgent Genetics’ proprietary technology platform has created a broad, flexible test menu and the ability to continually expand and improve its proprietary genetic reference library while maintaining accessible pricing, high accuracy and competitive...
Fulgent Genetics was the first clinical laboratory to offer copy number variation detection using NGS technology in the United States. Today, we continue to offer an unrivaled catalog of genetic testing, including over 18,000+ single gene tests, 900+ rare disease tests, whole genome sequencing, ...
Fulgent Genetics is a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health. Fulgent Genetics’ proprietary technology platform has created a broad, flexible test menu and the ability to continually expand and imp...